Furthermore, in mouse allografts of SHH MB authors (145) demonstrated uniform absence of MYCN, reduced proliferation and vascularity, as well as increase of apoptosis following in vivo treatment with PW-12, altogether resulting in a significant, more than five-fold decrease in tumor volume. The gene discussed is MYCN; the disease is neoplasm.